It was developed in the 1990s by Novo Nordisk and studied extensively in clinical trials for GH deficiency and wasting conditions, though it was ultimately not commercialized in favor of other compounds
The professional consensus in dermatology is: There is reasonable evidence for short-term brightening effects and antioxidant benefits at the cellular level Long-term safety and efficacy data are insufficient to make strong, universal clinical recommendations Medical supervision, appropriate dosing, and quality-controlled formulations are the essential safeguards that separate beneficial outcomes from adverse events WebMD's guide to glutathione provides a useful overview of potential risks and interactions for further reading
References Khavinson VKh
Importantly, detailed human pharmacokinetic and pharmacodynamic studies are essential to elucidate curcumins interaction profile, particularly with enhanced formulations
Works as a premium glutathione supplement for skin
Barry Conrad I want to say you get it all, like, depending on which side, is that it
